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ABSTRACT
Characteristics of infants exposed to maternal tuberculosis and chemoprophylaxis using
three months of isoniazid and rifampicin
Background: Though features of infants with congenital tuberculosis (TB) are known
including being low-birth-weight (LB\[D, features of in-utero TB-exposed infants including
non-infected are not well reported. Infants born to TB-infected women are at risk of
contracting TB post-delivery, therefore chemoprophylaxis is recommended, and this includes
use of isoniazid and rifampicin combination, but little is known about its effectiveness.
Objective: To determine features of in-utero TB-exposed infants and proportion with TB
after chemoprophylaxis with isoniazid and rifampicin.
Methods: Rekospective review of records of TB-infected women and their infants, from
2007-2010. Clinical features ofmothers and infants at time of delivery; and follow-up of
infants after completion of isoniazid andrifampicin are described.
Results: Eighty-eight infants born to 86 women with a diagnosis of TB were studied. TB
diagnosis was made peripartum in24.4%o of women, 23.3%had extra-pulmonary TB. Among
those diagnosed antepartum 46.2Yowere on treatrnent for >2 months. Human
immunodeficiency virus (tilV) was positiveingT.T%o;with CD4 count <200 cells/mm3 in
74.6%. Eight mothers (9.3%) died before discharge. There were 56 (63.6%) LBW and 45
(51.2%) preterm infants. Culture for acid-fast-bacilli was positive in 4 (4.5o/o) infants. At 3-
months follow-up, 17 Q0.2%) defaulted, and among 67 who returned, 7 (l0o/o) did not return
for Mantoux test reading, 1160 (1.7%) had positive Mantoux.
Conclusion: Majority of TB-exposed infants are born to mothers with TB/ HfV co-infection.
A high proportion of TB-exposed infants are born preterm and LBW. The high athition rate
made it difficult to assess effectiveness of chemoprophylaxis with isoniazid and rifampicin.
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